Test Price
2,800 AED✅ Home Collection Available
ARL11 Gene Tumor Predisposition Syndrome – Genetic Test in UAE
Executive Summary & Core Metrics
Precision genetic screening for pathogenic variants in the ARL11 gene associated with hereditary cancer predisposition syndromes, enabling proactive health management and personalised surveillance planning.
- Price: 2,800 AED – All-inclusive with clinical interpretation.
- Turnaround Time: 3–4 Weeks from sample receipt.
- Methodology: Next-Generation Sequencing (Illumina, GRCh38) with CNV calling.
- Accuracy: 99.9% analytical sensitivity and specificity.
- Logistics: VIP Mobile Phlebotomy & Temperature-Controlled Cold-Chain Home Collection (daily 8 AM – 11 PM).
- Clinical Support: Telephonic post-test guidance for result interpretation.
- Insurance: Direct billing verification via WhatsApp +971 54 548 8731.
Test Overview & Methodology
The ARL11 Genetic Test identifies inherited mutations in the ARL11 gene that increase lifetime risk for select malignancies. Detection of pathogenic or likely pathogenic variants allows for enhanced surveillance, risk-reducing interventions, and informed family counselling. Our laboratory employs next-generation sequencing (NGS) with full gene coverage including intronic boundaries and copy-number variant (CNV) detection, delivering clinically actionable results with the highest diagnostic yield.
| Feature | Our Test – ARL11 NGS | Closest Alternative – Single-Gene Sequencing |
|---|---|---|
| Precision | 99.9% analytical sensitivity & specificity (NGS) | ~95% sensitivity; may miss large rearrangements |
| Methodology | Next-Generation Sequencing (Illumina, GRCh38) with CNV calling | Sanger sequencing, limited to point mutations |
| Turnaround Time | 3–4 Weeks | 4–6 Weeks |
Physician Insight & Safety Protocols
“As a Consultant Medical Genetics specialist, I recognise that genetic testing for cancer predisposition can evoke anxiety. A positive result is not a cancer diagnosis — it is an opportunity for enhanced surveillance, risk reduction, and informed decision-making. Always discuss your results with your treating physician or a genetic counsellor.”
— Lina Osama Zaki Quteineh, Consultant Medical Genetics, DHA Registration ID: 9294403
Advisory & Safety Notice
Medication Warning:
Do not discontinue prescribed medication without consulting your doctor. Genetic findings are only one component of your overall health picture and must be interpreted within the full clinical context.
Exclusion Criteria & ER Red Flags
- Exclusion: Inability to provide informed consent; acute psychiatric instability that impairs understanding of genetic implications.
- ER Red Flag: Severe anxiety, panic attacks, or suicidal ideation following result disclosure — seek immediate medical help.
- Vulnerable populations: Minors require mandatory genetic counselling before testing, with consent from a legal guardian.
Patient FAQ & Clinical Guidance
1. What is the purpose of the ARL11 genetic test?
This test identifies inherited mutations in the ARL11 gene to assess your lifetime risk of developing certain cancers, enabling early detection and preventive measures. Results should be discussed with a genetic counsellor or oncologist.
2. How is the sample collected and when will results be ready?
A hospital-grade home collection service draws a small blood sample using cold-chain transport. Results are available within 3 to 4 weeks and include a full clinical interpretation report.
3. Does insurance cover the cost of the test?
Most UAE insurers cover genetic cancer risk tests when prescribed by an oncologist. Our team verifies your coverage directly via WhatsApp at +971 54 548 8731.
UAE Regulatory & Data Privacy Adherence
Data Protection & Clinical Compliance
This test is performed in full compliance with:
- Federal Decree-Law No. 45 of 2021 on Personal Data Protection (PDPL) – governing the processing and storage of your genetic and health data.
- Federal Law No. 2 of 2019 Concerning the Use of Information and Communication Technology in Health Fields – regulating digital health records and telemedicine.
- Federal Decree-Law No. 4 of 2016 on Medical Liability – ensuring patient safety, informed consent, and clinical accountability.
All genetic data is encrypted, access-controlled, and processed solely for diagnostic purposes. Your rights under PDPL include access, rectification, erasure, and data portability.
Clinical & Logistical Metadata
| Test Name | ARL11 Gene Tumor Predisposition Syndrome – Genetic Test (NGS) |
| Price (AED) | 2,800 AED |
| Turnaround Time | 3–4 Weeks |
| Sample Type / Matrix | Peripheral Whole Blood (3–5 mL in EDTA tube) |
| Methodology Used | Next-Generation Sequencing (Illumina, GRCh38) with CNV calling |
| ICD-10-CM Code | Z15.09 |
| LOINC Code | 55233-1 |
| DHA Facility License & Laboratory Address | DHA Facility License No. 1143 — DNA Labs UAE, Premises 105, Floor 1, Building 33, Dubai Healthcare City, Dubai, UAE |
دعم ثنائي اللغة متاح
التحقق من التغطية التأمينية
Check Insurance Coverage Instantly
Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.
توقف عن التخمين. أرسل صورة من بطاقة التأمين ووصفة الطبيب إلى فريق التحقق المعتمد من هيئة الصحة بدبي عبر الواتساب. احصل على تحديث الحالة في دقائق.
Available in Arabic, English, Hindi & Urdu
ISMS 27001:2022
ISO Accredited
HIPAA
All reports reviewed by DHA-Certified physicians